Gara Jalqabaatti › Kansarii Ovarii › Florida › Sarasota
Qorannoo klinikaalii Kansarii Ovarii Sarasota, FL keessatti
Qorannoo 16 Kansarii Ovarii f Sarasota fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Sarasota Memorial Health Care System, Sarasota
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- Florida Cancer Specialists, Sarasota
Study of AVZO-021 in Patients With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Avenzo Therapeutics Recruiting Site, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Florida Cancer Specialists, Sarasota
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Namoota walitti qabaa jiraSadarkaa 3
- Sarasota Memorial Health Care System, Sarasota
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Namoota walitti qabaa jiraSadarkaa 3
- Sarasota Memorial Health Care System, Sarasota
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
Namoota walitti qabaa jiraSadarkaa 3
- Sarasota Memorial Hospital ( Site 0075), Sarasota
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Namoota walitti qabaa jiraSadarkaa 3
- Sarasota Memorial Healthcare System, Sarasota
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Namoota walitti qabaa jiraSadarkaa 1
- SCRI - Florida Cancer Specialists, Sarasota
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Namoota walitti qabaa jira
- Florida Cancer Specialists - Sarasota, Sarasota
- Intercoastal Medical Group - Cattleridge II, Sarasota
- First Physicians Group - Gastroenterology Obesity Medicine, Sarasota
- fi 7 dabalataa
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Florida Cancer Specialists & Research Institute, Sarasota
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Florida Cancer Specialists, Sarasota
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
Namoota walitti qabaa jiraSadarkaa 2
- First Physicians Group /ID# 272180, Sarasota
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Namoota walitti qabaa jiraSadarkaa 1
- Dren Investigational Site, Sarasota
Qorannoo Kansarii Ovarii magaalota biroo keessatti
- Houston, TXQorannoo 89
- New York City, NYQorannoo 69
- Boston, MAQorannoo 61
- Los Angeles, CAQorannoo 50
- Nashville, TNQorannoo 49
- Arlington, VAQorannoo 46
- Philadelphia, PAQorannoo 44
- Columbus, OHQorannoo 39
- St. Louis, MOQorannoo 38
- Chicago, ILQorannoo 36
- San Antonio, TXQorannoo 31
- Cleveland, OHQorannoo 30
Qorannoo biroo Sarasota keessatti
- Kansara MetastatikiiQorannoo 19
- Kansara Qara'a Non-Small CellQorannoo 17
- Kansarii ColorectalQorannoo 16
- Kansa EndometiriyaaliiQorannoo 14
- Saree OljooQorannoo 12
- Saree (Gosoota Hunda)Qorannoo 11
- Kansaar Onnee Triple-NegativeQorannoo 8
- Dhibee QaraQorannoo 7
- Kansarii PancreasQorannoo 7
- Fibrillation AtrialQorannoo 7
- Kansarii ProstateQorannoo 6
- Dhukkubaa Harkaa SteatoticQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.